menu search

J&j (jnj) covid booster jab shows effectiveness against omicron

Johnson & Johnson's (JNJ) COVID booster vaccine demonstrates 85% effectiveness against COVID-related ho...

December 31, 2021, 1:00 pm

J&j (jnj) covid booster jab shows effectiveness against omicron

Johnson & Johnson's (JNJ) COVID booster vaccine demonstrates 85% effectiveness against COVID-related ho...

December 31, 2021, 1:00 pm

Goldman sachs plans to require covid boosters, mandate twice weekly testing

Goldman Sachs told employees Monday that all individuals coming into the bank's US offices will be required to show proof of a Covid vaccination ...

December 27, 2021, 6:18 pm

Goldman sachs plans to require covid boosters, mandate twice weekly testing

Goldman Sachs told employees Monday that all individuals coming into the bank's US offices will be required to show proof of a Covid vaccination ...

December 27, 2021, 6:18 pm

Goldman sachs plans to require covid boosters, mandate twice weekly testing

Goldman Sachs told employees Monday that all individuals coming into the bank's US offices will be required to show proof of a Covid vaccination ...

December 27, 2021, 6:18 pm

Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation

GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a ...

December 27, 2021, 1:46 pm

Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation

GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a ...

December 27, 2021, 1:46 pm

Geovax: a legitimate covid-19 phase 2 vaccine candidate trading at only a $25 million valuation

GOVX is uniquely positioned with its Phase 2 COVID-19 vaccine candidate for immunocompromised individuals. It has also started a Phase 2 trial as a ...

December 27, 2021, 1:46 pm

Fda authorizes pfizer boosters for 16- and 17-year-olds

The CDC still needs to sign off on the boosters for teens....

December 9, 2021, 1:22 pm

Fda authorizes pfizer boosters for 16- and 17-year-olds

The CDC still needs to sign off on the boosters for teens....

December 9, 2021, 1:22 pm

Fda authorizes pfizer boosters for 16- and 17-year-olds

The CDC still needs to sign off on the boosters for teens....

December 9, 2021, 1:22 pm

Fda expands emergency use of pfizer/biontech's covid-19 booster to 16 years & older

The FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of Pfizer Inc (NYSE: P...

December 9, 2021, 1:16 pm

Fda expands emergency use of pfizer/biontech's covid-19 booster to 16 years & older

The FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of Pfizer Inc (NYSE: P...

December 9, 2021, 1:16 pm

Fda expands emergency use of pfizer/biontech's covid-19 booster to 16 years & older

The FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of Pfizer Inc (NYSE: P...

December 9, 2021, 1:16 pm

Why biontech stock is sliding today

Good news about a booster dose with the omicron variant could be bad news for the biotech's future sale...

December 8, 2021, 1:17 pm

Why biontech stock is sliding today

Good news about a booster dose with the omicron variant could be bad news for the biotech's future sale...

December 8, 2021, 1:17 pm

Why biontech stock is sliding today

Good news about a booster dose with the omicron variant could be bad news for the biotech's future sale...

December 8, 2021, 1:17 pm

Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population

Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...

December 3, 2021, 1:31 pm

Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population

Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...

December 3, 2021, 1:31 pm

Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population

Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...

December 3, 2021, 1:31 pm


Search within

Pages Search Results: